Estrogen receptor-mediated processes in normal and cancer cells.
about
Current perspectives between metabolic syndrome and cancerDepurinating estrogen-DNA adducts, generators of cancer initiation: their minimization leads to cancer preventionThe molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessityStructural Basis for Ca2+-induced Activation and Dimerization of Estrogen Receptor by CalmodulinEstrogen receptor positive breast cancers and their association with environmental factorsLiver is a target of arsenic carcinogenesisTransplacental arsenic carcinogenesis in miceEstrogen utilization of IGF-1-R and EGF-R to signal in breast cancer cells.Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study.Arsenic abrogates the estrogen-signaling pathway in the rat uterusOral contraceptive use and estrogen/progesterone receptor-negative breast cancer among African American women.Morphologic transformation of human breast epithelial cells MCF-10A: dependence on an oxidative microenvironment and estrogen/epidermal growth factor receptorsEstrogen enhances the efficacy of an oncolytic HSV-1 mutant in the treatment of estrogen receptor-positive breast cancer.Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.Reproductive and exogenous hormone factors in relation to risk of meningioma in women: a meta-analysis.Circulating sex hormones and terminal duct lobular unit involution of the normal breast.Signaling within a coactivator complex: methylation of SRC-3/AIB1 is a molecular switch for complex disassembly.Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models.Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers.Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cellsReproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies.Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case-case comparisonCirculating sex steroids and breast cancer risk in premenopausal women.Serum organochlorines and breast cancer: a case-control study among African-American womenThe etiology and prevention of breast cancerInhibition of estrogen-induced mammary tumor formation in MMTV-aromatase transgenic mice by 4-chlorophenylacetate.Reduced risk of breast cancer associated with recreational physical activity varies by HER2 status.Alterations in estrogen signalling pathways upon acquisition of anthracycline resistance in breast tumor cellsDecursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells.Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer.Synthesis and evaluation of 11β-(4-substituted phenyl) estradiol analogs: transition from estrogen receptor agonists to antagonists.Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up.The Proliferative Activity of Mammary Epithelial Cells in Normal Tissue Predicts Breast Cancer Risk in Premenopausal Women.Arsenic-induced aberrant gene expression in fetal mouse primary liver-cell cultures.Dietary fat, tamoxifen use and circulating sex hormones in postmenopausal breast cancer survivors.Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: a pooled analysis.Chemoprevention of Rat Mammary Carcinogenesis by Apiaceae SpicesDelayed and persistent ERK1/2 activation is required for 4-hydroxytamoxifen-induced cell death.Enhancing effects of beta-estradiol 3-benzoate but not methoxychlor on the promotion/progression stage of chemically-induced mammary carcinogenesis in ovariectomized rats.The consequence of NAC on sodium arsenite-induced uterine oxidative stress.
P2860
Q26749299-C801A523-45A5-4EA5-A31A-EC1F5B9D7F90Q26765412-24D70BF6-B370-4DE5-BD0E-D7A8CA8289A3Q27021258-E406EB93-C7EA-4E4F-BB4D-FC4AB13FD4BBQ27676878-2EDB5CC6-B1C0-498E-A0EA-60C4F7242160Q28388714-CD187929-BBE3-44B2-BE68-61D9AC91F86AQ28390690-F80EF7B2-D543-4254-9DBB-25093C9BC6C7Q28396711-8EF01C08-4678-423C-B26A-AE0AA34B3CA1Q30433113-B7FCCC74-E353-4F08-A855-41BA7AA49BEBQ33248484-B2941851-9454-4809-AECB-53D6D665147CQ34016904-C1F987AB-E582-45B4-9897-729FD8BEE2EDQ34057842-8D21F818-15A8-40B5-9236-7183D3F9C5E9Q34148850-35006200-AE39-49CE-A7A2-8E2382D477CFQ34601083-2823C15A-55B7-4A3A-81F2-DD66FE33B2CFQ35029543-33D5655D-5432-41A4-B16A-F49029C392F8Q35080237-A058BF26-62ED-40CA-B153-53657614C96DQ35098777-8DAA5BB6-0CD9-4776-8AEE-27A60F6826CDQ35131447-A50DCFD2-C56D-4E3E-AAD6-24D622B03969Q35157919-12A4491A-C9D0-4D69-8923-F015EB229D43Q35575724-A66284FA-2967-48A1-884E-F5FD60CCB212Q35585136-32039FDE-42E1-4B69-A888-5294480023A5Q35605749-DAD941A6-1413-4A04-B67D-C92C1A8FDA9BQ35605821-339CF9B8-3839-4186-9539-DEF765415D98Q35659606-9E4C64E7-4F0E-440A-AD5C-588089321882Q35728963-E0D4149C-ADF2-4400-BF5E-7C99D70E4DA9Q35910615-53122371-32DF-4AF1-A656-0315B8EE7512Q35925387-1E227557-D5F2-4EEF-BF4B-DFCBBD112699Q35928943-AAFDB755-881F-46C8-B342-8ED079DAD29DQ36280127-8DC27DC9-7BF9-4C0E-8D06-185F5AEE5149Q36465269-3D569CFC-C9D6-474A-8EB7-21129CE55EA2Q36624258-66C1C99F-5B40-495D-B48C-1263113963A0Q36635650-CB551BD9-8C3C-40CC-9F63-CA8842532B9AQ36638994-B3568CDC-8F78-4119-BE96-CDEA602A8E1CQ36918165-EC673A4E-A4E9-40A2-B192-F651EF023208Q37231348-9440C97D-9B58-47A3-AD60-AFF797E1106DQ37355711-7A4CA28B-AB8B-47A3-8D42-CBC6E247E72AQ37586779-12577799-D5B0-4AA4-9F2A-82886D443E1DQ37691006-6EDD17C1-C725-4748-BC1E-E80F86EB6757Q40765604-B3335134-E8CE-4FA9-BEC0-C41742B9B802Q44083579-8A270F7D-3506-436E-A475-CAF0A455D198Q52670807-5C7B665C-15B2-4668-8E62-59D00F974D27
P2860
Estrogen receptor-mediated processes in normal and cancer cells.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Estrogen receptor-mediated processes in normal and cancer cells.
@ast
Estrogen receptor-mediated processes in normal and cancer cells.
@en
Estrogen receptor-mediated processes in normal and cancer cells.
@nl
type
label
Estrogen receptor-mediated processes in normal and cancer cells.
@ast
Estrogen receptor-mediated processes in normal and cancer cells.
@en
Estrogen receptor-mediated processes in normal and cancer cells.
@nl
prefLabel
Estrogen receptor-mediated processes in normal and cancer cells.
@ast
Estrogen receptor-mediated processes in normal and cancer cells.
@en
Estrogen receptor-mediated processes in normal and cancer cells.
@nl
P1476
Estrogen receptor-mediated processes in normal and cancer cells.
@en
P2093
Dickson RB
Stancel GM
P304
P577
2000-01-01T00:00:00Z